Fresenius has reported a steady first quarter after a challenging 2018 for the German healthcare group. Net income was up 3% to €465m (US$521.1m) on sales that rose 8% to €8.5bn. The group also confirmed its full year guidance figures. Fresenius is projecting sales growth of 3% to 6% in constant currency. Net income is…